Advertisement

Bladder Cancer

  • Manolis KogevinasEmail author
Chapter
  • 68 Downloads

Abstract

Tumors of the urinary bladder contribute significantly to the overall human cancer burden with approximately 550,000 new cases per year worldwide. Of those, around 425,000 occur in men, and about two-thirds occur in high income countries. Occupation has been identified, after smoking, as the second important risk factor for bladder cancer causing possibly around 10% of all cancers although there is a considerable variation of this percentage between sexes and geographical regions. Several exposures, occupations, and industries have been associated with increased bladder cancer risk. Aromatic amines (benzidine, 4-aminobiphenyl, b-naphthylamine, ortho-toluidine) in dyestuff manufacture and in the rubber and other industries are specific agents in the workplace which have been unequivocally associated with bladder cancer. Exposure to polycyclic aromatic hydrocarbons (PAHs) in aluminum process workers and other industries has also been clearly associated with bladder cancer. Excess risks have been observed among painters, machinists and other metal workers, workers in the textile industry, printers, hairdressers, dry cleaners, and transport workers. Exposures associated with the increased risk in these occupations/industries include PAHs, industrial oils/cutting fluids, diesel engine exhaust, paints, dyes, chlorinated hydrocarbon solvents, and metals.

Keywords

Bladder cancer Occupational bladder cancer Aromatic amines 4-Aminobiphenyl Benzidine Polycyclic aromatic hydrocarbons (PAHs) Diesel engine exhaust Occupational exposure assessment 

References

  1. 1.
    Cumberbatch MG, Cox A, Teare D, Catto JW. Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol. 2015;1(9):1282–90. Review. Erratum in: JAMA Oncol. 2015;1(9):1224.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Marant Micallef C, Shield KD, Baldi I, Charbotel B, Fervers B, Gilg Soit Ilg A, Guénel P, Olsson A, Rushton L, Hutchings SJ, Straif K, Soerjomataram I. Occupational exposures and cancer: a review of agents and relative risk estimates. Occup Environ Med. 2018;75(8):604–14.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    IARC. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. Monographs on the evaluation of carcinogenic risks to humans, vol. 92. Lyon: IARC; 2010.Google Scholar
  4. 4.
    IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol. 100 F. A review of human carcinogens. Part F: chemical agents and related occupations. Lyon: IARC; 2012.Google Scholar
  5. 5.
    Theriault G, Tremblay C, Cordier S, Gingras S. Bladder cancer in the aluminium industry. Lancet. 1984;323:947–50.CrossRefGoogle Scholar
  6. 6.
    Bosetti C, Boffetta P, La Vecchia C. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann Oncol. 2007;18(3):431–46.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Armstrong BG, Hutchinson E, Fletcher T. Cancer risk following exposure to Polycyclic Aromatic Hydrocarbons (PAHs): a meta-analysis (Rep. No. 068). Sudbury: Health and Safety Executive; 2002. http://hse.gov.uk/research.rrhtm/rr068.htm. Accessed 15 May 2013.Google Scholar
  8. 8.
    Gibbs GW, Labrèche F, Busque MA, Duguay P. Mortality and cancer incidence in aluminum smelter workers: a 5-year update. J Occup Environ Med. 2014;56(7):739–64.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    IARC. Some aromatic amines, organic dyes, and related exposures. Monographs on the evaluation of carcinogenic risks to humans, vol. 99. Lyon: IARC; 2010.Google Scholar
  10. 10.
    Collins JJ, Strauss ME, Levinskas GJ, Conner PR. The mortality experience of workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a trichlorophenol process accident. Epidemiology. 1993;4:7–13.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    IARC. Some drinking-water disinfectants and contaminants, including arsenic. Monographs on the evaluation of carcinogenic risks to humans, vol. 84. Lyon: IARC; 2004.Google Scholar
  12. 12.
    IARC. Monographs on the evaluation of carcinogenic risks to humans. Vol. 100C. A review of human carcinogens. Part C: arsenic, metals, fibres, and dusts. Lyon: IARC; 2012.Google Scholar
  13. 13.
    Keil AP, Richardson DB. Reassessing the link between airborne arsenic exposure among anaconda copper smelter workers and multiple causes of death using the parametric g-formula. Environ Health Perspect. 2017;125(4):608–14.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Case RA, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954;11:75–104.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Carreón T, Ruder AM, Schulte PA, et al. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine. Int J Cancer. 2006;118:161–8.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Rubino GF, Scansetti G, Piolatto G, Pira E. The carcinogenic effect of aromatic amines: an epidemiological study on the role of o-toluidine and 4,4′-methylene bis (2-methylaniline) in inducing bladder cancer in man. Environ Res. 1982;27:241–54.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Veys CA. Bladder tumours in rubber workers: a factory study 1946–1995. Occup Med (Lond). 2004;54(5):322–9.CrossRefGoogle Scholar
  18. 18.
    IARC. Painting, firefighting, and shiftwork. Monographs on the evaluation of carcinogenic risks to humans, vol. 98. Lyon: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; 2010.Google Scholar
  19. 19.
    Guha N, Steenland NK, Merletti F, Altieri A, Cogliano V, Straif K. Bladder cancer risk in painters: a meta-analysis. Occup Environ Med. 2010;67(8):568–73.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Bachand A, Mundt KA, Mundt DJ, Carlton LE. Meta-analyses of occupational exposure as a painter and lung and bladder cancer morbidity and mortality 1950-2008. Crit Rev Toxicol. 2010;40:101–25.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    IARC. Overall evaluations of carcinogenicity: an updating of IARC monographs. Vol. 1–42. IARC Monographs Supplement 7. Lyon: IARC; 1987.Google Scholar
  22. 22.
    IARC. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 28. The rubber industry. Lyon: International Agency for Research on Cancer; 1982.Google Scholar
  23. 23.
    Kogevinas M, Sala M, Boffetta P, Kazerouni N, Kromhout H, Hoar-Zahm S. Cancer risk in the rubber industry. A review of the recent epidemiological evidence. Occup Environ Med. 1998;55:1–12.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Boniol M, Koechlin A, Boyle P. Meta-analysis of occupational exposures in the rubber manufacturing industry and risk of cancer. Int J Epidemiol. 2017;46(6):1940–7.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Ward MH, et al. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J Natl Cancer Inst. 1991;83:501–6.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Carreón T, Hein MJ, Viet SM, et al. Increased bladder cancer risk among workers exposed to o-toluidine and aniline: a reanalysis. Occup Environ Med. 2010;67:348–50.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Sorahan T, Hamilton L, Jackson JR. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-beta-naphthylamine and o-toluidine. Occup Environ Med. 2000;57:106–15.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Sorahan T. Bladder cancer risks in workers manufacturing chemicals for the rubber industry. Occup Med (Lond). 2008;58:496–501.CrossRefGoogle Scholar
  29. 29.
    IARC. Ionizing radiation, part 1: x- and gamma (γ)-radiation, and neutrons. Monographs on the evaluation of carcinogenic risks to humans, vol. 75. Lyon: IARC; 2000.Google Scholar
  30. 30.
    IARC. monographs on the evaluation of carcinogenic risks to humans. Vol. 100D. A review of human carcinogens. Part D. Radiation. Lyon: IARC; 2012.Google Scholar
  31. 31.
    Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res. 2007;168:1–64.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Stasik MJ. Carcinomas of the urinary bladder in a 4-chloro-o-toluidine cohort. Int Arch Occup Environ Health. 1988;60:21–4.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Popp W, Schmieding W, Speck M, et al. Incidence of bladder cancer in a cohort of workers exposed to 4-chloro-o-toluidine while synthesising chlordimeform. Br J Ind Med. 1992;49:529–31.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Boffetta P, Burstyn I, Partanen T, et al. Cancer mortality among European asphalt workers: an international epidemiological study. I. Results of the analysis based on job titles. Am J Ind Med. 2003;43:18–27.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Burstyn I, Kromhout H, Johansen C, et al. Bladder cancer incidence and exposure to polycyclic aromatic hydrocarbons among asphalt pavers. Occup Environ Med. 2007;64:520–6.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    IARC. Dry cleaning, some chlorinated solvents and other industrial chemicals. Monographs on the evaluation of carcinogenic risks to humans, vol. 63. Lyon: IARC; 1995.Google Scholar
  37. 37.
    Blair A, Petralia SA, Stewart PA. Extended mortality follow-up of a cohort of dry cleaners. Ann Epidemiol. 2003;13:50–6.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Calvert GM, Ruder AM, Petersen MR. Mortality and end-stage renal disease incidence among dry cleaning workers. Occup Environ Med. 2011;68:709–16.PubMedCrossRefPubMedCentralGoogle Scholar
  39. 39.
    Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparén P, Tryggvadottir L, Weiderpass E, Kjaerheim K. Occupation and cancer—follow-up of 15 million people in five Nordic countries. Acta Oncol. 2009;48(5):646–790.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Silverman DT, Levin LI, Hoover RN. Occupational risks of bladder cancer in the United States: II Nonwhite men. J Natl Cancer Inst. 1989;81:1480–3.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Kogevinas M, ‘t Mannetje A, Cordier S, Ranft U, González CA, Vineis P, Chang-Claude J, Lynge E, Wahrendorf J, Tzonou A, Jöckel KH, Serra C, Porru S, Hours M, Greiser E, Boffetta P. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control. 2003;14:907–14.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Vlaanderen J, Straif K, Ruder A, Blair A, Hansen J, Lynge E, Charbotel B, Loomis D, Kauppinen T, Kyyronen P, Pukkala E, Weiderpass E, Guha N. Tetrachloroethylene exposure and bladder cancer risk: a meta-analysis of dry-cleaning-worker studies. Environ Health Perspect. 2014;122(7):661–6.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    IARC. Diesel and gasoline engine exhausts and some nitroarenes. Monographs on the evaluation of carcinogenic risks to humans, vol. 105. Lyon: IARC; 2014.Google Scholar
  44. 44.
    Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman DT. The diesel exhaust in miners study: a cohort mortality study with emphasis on lung cancer. J Natl Cancer Inst. 2012;104:869–83.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Latifovic L, Villeneuve PJ, Parent MÉ, Johnson KC, Kachuri L, Canadian Cancer Registries Epidemiology Group, Harris SA. Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men. Cancer Med. 2015;4(12):1948–62.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Pukkala E. Occupation and risk of bladder cancer in nordic countries. J Occup Environ Med. 2016;58(8):e301–7.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Mannetje A, Kogevinas M, Chang-Claude J, Cordier S, Gónzalez CA, Hours M, et al. Occupation and bladder cancer in European women. Cancer Causes Control. 1999;10:209–17.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    IARC. Printing processes and printing inks, carbon black and some nitro compounds. Monographs on the evaluation of carcinogenic risks to humans, vol. 65. Lyon: International Agency for Research on Cancer; 1996.Google Scholar
  49. 49.
    Evanoff BA, Gustavsson P, Hogstedt C. Mortality and incidence of cancer in a cohort of Swedish chimney sweeps: an extended follow up study. Br J Ind Med. 1993;50(5):450–9.PubMedPubMedCentralGoogle Scholar
  50. 50.
    IARC. Trichloroethylene, tetrachloroethylene and some other chlorinated agents. Monographs on the evaluation of carcinogenic risks to humans, vol. 106. Lyon: IARC; 2014.Google Scholar
  51. 51.
    Lynge E, Andersen A, Rylander L, et al. Cancer in persons working in dry cleaning in the Nordic countries. Environ Health Perspect. 2006;114:213–9.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    IARC. Some industrial chemicals. Monographs on the evaluation of carcinogenic risks to humans, vol. 115. Lyon: IARC; 2018.Google Scholar
  53. 53.
    Sorahan T. Cancer risks in chemical production workers exposed to 2-mercaptobenzothiazole. Occup Environ Med. 2009;66(4):269–73.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Collins JJ, Strauss ME, Riordan SG. Mortalities of workers at the Nitro plant with exposure to 2-mercaptobenzothialzole. Occup Environ Med. 1999;56(10):667–71.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    IARC. Some flame retardants and textile chemicals, and exposures in the textile manufacturing industry. Monographs on the evaluation of carcinogenic risks to humans, vol. 48. Lyon: IARC; 1990.Google Scholar
  56. 56.
    Serra C, Kogevinas M, Silverman DT, Turuguet D, Tardon A, Garcia-Closas R, Carrato A, Castaño-Vinyals G, Fernandez F, Stewart P, Benavides FG, Gonzalez S, Serra A, Rothman N, Malats N, Dosemeci M. Work in the textile industry in Spain and bladder cancer. Occup Environ Med. 2008;65:552–9.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Wernli KJ, Ray RM, Gao DL, Thomas DB, Checkoway H. Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989–1998. Am J Ind Med. 2003;44(6):595–9.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Vineis P, Pirastu R. Aromatic amines and cancer. Cancer Causes Control. 1997;8:346–55.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Case RA, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. 1954. Br J Ind Med. 1993;50:389–411.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Decarli A, Peto J, Piolatto G, La Vecchia C. Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis. Br J Cancer. 1985;51:707–12.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Meigs JW, Marrett LD, Ulrich FU, Flannery JT. Bladder tumor incidence among workers exposed to benzidine: a thirty-year follow-up. J Natl Cancer Inst. 1986;76:1–8.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Schulte PA, Knut R, Hemstreet GP, Altekruse EB, Gullen WH, Tillett S, Allsbrook WC, Crosby JH, Witherington R, Stringer W, Brubaker MM. Risk factors for bladder cancer in a cohort exposed to aromatic amines. Cancer. 1986;58:2156–62.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Risch HA, Burch JD, Miller AB, Hill GB, Steele R, Howe GR. Occupational factors and the incidence of cancer of the bladder in Canada. Br J Ind Med. 1988;45(6):361–7.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Sorahan T, Sole G. Coarse fishing and urothelial cancer: a regional case-control study. Br J Cancer. 1990;62:138–41.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Checkoway H, Smith AH, McMichael AJ, Jones FS, Monson RR, Tyroler HA. A case-control study of bladder cancer in the United States rubber and tyre industry. Br J Ind Med. 1981;38(3):240–6.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Delzell E, Monson R. Mortality among rubber workers. III. Cause-specific mortality, 1940–1978. J Occup Med. 1981;23:677–84.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Taeger D, Weiland SK, Sun Y, Keil U, Straif K. Cancer and non-cancer mortality in a cohort of recent entrants (1981–2000) to the German rubber industry. Occup Environ Med. 2007;64(8):560–1.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Boniol M, Koechlin A, Świątkowska B, Sorahan T, Wellmann J, Taeger D, Jakobsson K, Pira E, Boffetta P, La Vecchia C, Pizot C, Boyle P. Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975. Ann Oncol. 2016;27(5):933–41.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Siemiatycki J, Dewar R, Nadon L, Gerin M. Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol. 1994;140:1061–80.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Maltseva A, Serra C, Kogevinas M. Cancer risk among workers of a secondary aluminium smelter. Occup Med (Lond). 2016;66(5):412–4.CrossRefGoogle Scholar
  71. 71.
    Partanen T, Boffetta P. Cancer risk in asphalt workers and roofers: review and meta-analysis of epidemiologic studies. Am J Ind Med. 1994;26(6):721–40.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control. 1997;8:444–72.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Rota M, Bosetti C, Boccia S, Boffetta P, La Vecchia C. Occupational exposures to polycyclic aromatic hydrocarbons and respiratory and urinary tract cancers: an updated systematic review and a meta-analysis to 2014. Arch Toxicol. 2014;88(8):1479–90.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol. 1986;124:578–89.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Jensen OM, Wahrendorf J, Knudsen JB, Sorensen BL. The Copenhagen case-referent study on bladder cancer. Risks among drivers, painters and certain other occupations. Int J Cancer. 1987;13:129–34.Google Scholar
  76. 76.
    Schifflers E, Jamart J, Renard V. Tobacco and occupation as risk factors in bladder cancer: a case-control study in southern Belgium. Int J Cancer. 1987;39:287–92.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Steineck G, Plato N, Gerhardsson M, Norell SE, Hogstedt C. Increased risk of urothelial cancer in Stockholm during 1985–87 after exposure to benzene and exhausts. Int J Cancer. 1990;45(6):1012–7.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Bonassi S, Merlo F, Pearce N, Puntoni R. Bladder cancer and occupational exposure to polycyclic aromatic hydrocarbons. Int J Cancer. 1989;44(4):648–51.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Clavel J, Mandereau L, Limasset JC, Hemon D, Cordier S. Occupational exposure to polycyclic aromatic hydrocarbons and the risk of bladder cancer: a French case-control study. Int J Epidemiol. 1994;23:1145–53.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Band PR, Le ND, MacArthur AC, Fang R, Gallagher RP. Identification of occupational cancer risks in British Columbia: a population-based case-control study of 1129 cases of bladder cancer. J Occup Environ Med. 2005;47(8):854–8.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Kellen E, Zeegers M, Paulussen A, Vlietinck R, Vlem EV, Veulemans H, Buntinx F. Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk. Cancer Lett. 2007;245(1–2):51–60.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Siemiatycki J, Gerin M, Stewart P, Nadon L, Dewar R, Richardson L. Associations between several sites of cancer and ten types of exhaust and combustion products. Results from a case-referent study in Montreal. Scand J Work Environ Health. 1988;14(2):79–90.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    La Vecchia C, Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev. 1995;4:31–43.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Hadkhale K, MacLeod J, Demers PA, Martinsen JI, Weiderpass E, Kjaerheim K, Lynge E, Sparen P, Tryggvadottir L, Anne Harris M, Tjepkema M, Peters PA, Pukkala E. Occupational variation in incidence of bladder cancer: a comparison of population-representative cohorts from Nordic countries and Canada. BMJ Open. 2017;7(8):e016538.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Samanic CM, Kogevinas M, Silverman DT, Tardón A, Serra C, Malats N, Real FX, Carrato A, García-Closas R, Sala M, Lloreta J, Rothman N, Dosemeci M. Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med. 2008;65:347–53.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Cartwright R. Occupational bladder cancer and cigarette smoking in West Yorkshire. Scand J Work Environ Health. 1982;8(Suppl 1):79–82.PubMedPubMedCentralGoogle Scholar
  87. 87.
    Cordier S, Clavel J, Limasset JC, Boccon-Gibod L, Moua NLE, Mandereau L, et al. Occupational risks of bladder cancer in France: a multicentric case-control study. Int J Epidemiol. 1993;22:403–11.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    González CA, López-Abente G, Errezola M, Escolar A, Riboli E, Izarzugaza I, Nebot M. Occupation and bladder cancer in Spain: a multi-centre case-control study. Int J Epidemiol. 1989;18(3):569–77.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Vineis P, Magnani C. Occupation and bladder cancer in males: a case-control study. Int J Cancer. 1985;35:599–606.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Kabat GC, Dieck GS, Wynder EL. Bladder cancer in nonsmokers. Cancer. 1986;57(2):362–7.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Morrison AS, Ahlbom A, Verhoek WG, Aoki K, Leck I, Ohno Y, Obata K. Occupation and bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. J Epidemiol Community Health. 1985;39:294–300.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Silverman DT, Levin L, Hoover RN. Occupational risks of bladder cancer among white women in the United States. Am J Epidemiol. 1990;132:453–61.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Colt JS, Karagas MR, Schwenn M, Baris D, Johnson A, Stewart P, Verrill C, Moore LE, Lubin J, Ward MH, Samanic C, Rothman N, Cantor KP, Beane Freeman LE, Schned A, Cherala S, Silverman DT. Occupation and bladder cancer in a population-based case-control study in Northern New England. Occup Environ Med. 2011;68(4):239–49.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Porru S, Aulenti V, Donato F, Boffetta P, Fazioli R, CoscianiCunico S, et al. Bladder cancer and occupation: a case-control study in northern Italy. Occup Environ Med. 1996;53:6–10.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    La Vecchia C, Negri E, D’Avanzo B, Franceschi S. Occupation and the risk of bladder cancer. Int J Epidemiol. 1990;19:264–8.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Colt JS, Friesen MC, Stewart PA, Donguk P, Johnson A, Schwenn M, Karagas MR, Armenti K, Waddell R, Verrill C, Ward MH, Freeman LE, Moore LE, Koutros S, Baris D, Silverman DT. A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men. Occup Environ Med. 2014;71(10):667–74.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Colin R, Grzebyk M, Wild P, Hédelin G, Bourgkard È. Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories. Occup Environ Med. 2018;75(5):328–36.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Hadkhale K, Martinsen JI, Weiderpass E, Kjaerheim K, Sparen P, Tryggvadottir L, Lynge E, Pukkala E. Occupational exposure to solvents and bladder cancer: a population-based case control study in Nordic countries. Int J Cancer. 2017;140(8):1736–46.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Steenland K, Zhao L, Winquist A. A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). Occup Environ Med. 2015;72(5):373–80.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Allen EM, Alexander BH, MacLehose RF, Nelson HH, Ramachandran G, Mandel JH. Cancer incidence among Minnesota taconite mining industry workers. Ann Epidemiol. 2015;25(11):811–5.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    McElvenny DM, Miller BG, MacCalman LA, Sleeuwenhoek A, van Tongeren M, Shepherd K, Darnton AJ, Cherrie JW. Mortality of a cohort of workers in Great Britain with blood lead measurements. Occup Environ Med. 2015;72(9):625–32.PubMedCrossRefPubMedCentralGoogle Scholar
  102. 102.
    Steenland K, Barry V, Anttila A, Sallmén M, McElvenny D, Todd AC, Straif K. A cohort mortality study of lead-exposed workers in the USA, Finland and the UK. Occup Environ Med. 2017;74(11):785–91.CrossRefGoogle Scholar
  103. 103.
    Reulen RC, Kellen E, Buntinx F, Brinkman M, Zeegers MP. A meta-analysis on the association between bladder cancer and occupation. Scand J Urol Nephrol Suppl. 2008;218:64–78.CrossRefGoogle Scholar
  104. 104.
    Koutros S, Silverman DT, Alavanja MC, Andreotti G, Lerro CC, Heltshe S, Lynch CF, Sandler DP, Blair A, Beane Freeman LE. Occupational exposure to pesticides and bladder cancer risk. Int J Epidemiol. 2016;45(3):792–805.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Leveque-Morlais N, Tual S, Clin B, Adjemian A, Baldi I, Lebailly P. The AGRIculture and CANcer (AGRICAN) cohort study: enrollment and causes of death for the 2005–2009 period. Int Arch Occup Environ Health. 2015;88(1):61–73.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Boulanger M, Tual S, Lemarchand C, Guizard AV, Velten M, Marcotullio E, Baldi I, Clin B, Lebailly P. Agricultural exposure and risk of bladder cancer in the AGRIculture and CANcer cohort. Int Arch Occup Environ Health. 2017;90(2):169–78.  https://doi.org/10.1007/s00420-016-1182-y. Epub 2016 Nov 4. PubMed PMID: 27815726.CrossRefPubMedPubMedCentralGoogle Scholar
  107. 107.
    Amr S, Dawson R, Saleh DA, Magder LS, Mikhail NN, St George DM, Squibb K, Khaled H, Loffredo CA. Agricultural workers and urinary bladder cancer risk in Egypt. Arch Environ Occup Health. 2014;69(1):3–10.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Jackson SS, St George DM, Loffredo CA, Amr S. Nonoccupational exposure to agricultural work and risk of urinary bladder cancer among Egyptian women. Arch Environ Occup Health. 2017;72(3):166–72.PubMedCrossRefPubMedCentralGoogle Scholar
  109. 109.
    Barbone F, Franceschi S, Talamini R, Bidoli E, La Vecchia C. Occupation and bladder cancer in Pordenone (North-East Italy): a case-control study. Int J Epidemiol. 1994;23:58–65.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    ‘t Mannetje A, Pearce N. Bladder cancer risk in sales workers: artefact or cause for concern? Am J Ind Med. 2006;49(3):175–86.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Anton-Culver H, Lee-Feldstein A, Taylor TH. Occupation and bladder cancer risk. Am J Epidemiol. 1992;136(1):89–94.PubMedCrossRefPubMedCentralGoogle Scholar
  112. 112.
    Maffi L, Vineis P. Occupation and bladder cancer in females. Med Lav. 1986;77(5):511–4.PubMedPubMedCentralGoogle Scholar
  113. 113.
    Piper JM, Matanoski GM, Tonascia J. Bladder cancer in young women. Am J Epidemiol. 1986;123:1033–42.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Swanson GM, Burns PB. Cancer incidence among women in the workplace: a study of the association between occupation and industry and 11 cancer sites. J Occup Environ Med. 1995;37:282–7.PubMedCrossRefPubMedCentralGoogle Scholar
  115. 115.
    Simpson J, Roman E, Law G, Pannett B. Women’s occupation and cancer: preliminary analysis of cancer registrations in England and Wales, 1971-1990. Am J Ind Med. 1999;36:172–85.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Cole P, Hoover R, Friedell GH. Occupational and cancer of the lower urinary tract. Cancer. 1972;29:1250–60.PubMedCrossRefPubMedCentralGoogle Scholar
  117. 117.
    Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981;66:1191–308.PubMedCrossRefPubMedCentralGoogle Scholar
  118. 118.
    Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health. 1991;46:6–15.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Silverman DT, Levin LI, Hoover RN, Hartge P. Occupational risks of bladder cancer in the United States: I. White men. J Natl Cancer Inst. 1989;81(19):1472–80.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Brown T, Slack R, Rushton L, British Occupational Cancer Burden Study Group. Occupational cancer in Britain. Urinary tract cancers: bladder and kidney. Br J Cancer. 2012;107(Suppl 1):S76–84.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Labrèche F, Duguay P, Boucher A, Arcand R. But other than mesothelioma? An estimate of the proportion of work-related cancers in Quebec. Curr Oncol. 2016;23(2):e144–9.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Pearce N, Matos E, Vainio H, Boffetta P, Kogevinas M, editors. Occupational cancer in developing countries. IARC Scientific Publications No 129. Lyon: IARC; 1994. p. 63–95.Google Scholar
  123. 123.
    Silverman DT, Koutros S, Figueroa JD, Prokunina-Olsson L, Rothman N. Bladder cancer. In: Thun MJ, Linet MS, Cerhan JR, Haiman C, Schottenfeld D, editors. Schottenfeld and Fraumeni: cancer epidemiology and prevention. 4th ed. New York: Oxford Press; 2018. p. 977–96.Google Scholar
  124. 124.
    Kogevinas M, Figueroa J, Garcia-Closas M, Mucci L. Chapter 22: Urinary bladder cancer. In: Adami HO, Hunter D, Lagiou P, Mucci L, editors. Textbook of cancer epidemiology. 3rd ed. New York: Oxford University Press; 2018.Google Scholar
  125. 125.
    IARC. Pathology and genetics of tumors of the urinary system and male genital organs. In: Epstein JI, Eble JN, Sesterhenn I, Sauter G, editors. World health organization classification of tumors, vol. 7. Lyon: IARC Press; 2004. p. 93.Google Scholar
  126. 126.
    Kauppinen T, Toikkanen J, Pedersen D, Young R, Ahrens W, Boffetta P, Hansen J, Kromhout H, Maqueda J, Mirabelli D, de la Orden V, Pannett B, Plato N, Savela A, Vincent R, Kogevinas M. Occupational exposure to carcinogens in the European Union. Occup Environ Med. 2000;57:10–8.PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103(24):1827–39.PubMedPubMedCentralCrossRefGoogle Scholar
  128. 128.
    Schoenberg JB, Stemhagen A, Mogielnicki AP, Altman R, Abe T, Mason TJ. Case-control study of bladder cancer in New Jersey. I. Occupational exposures in white males. J Natl Cancer Inst. 1984;72(5):973–81.PubMedPubMedCentralGoogle Scholar
  129. 129.
    Kiemeney LA, Schoenberg M. Familial transitional cell carcinoma. J Urol. 1996;156(3):867–72.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Pina K, Hemminki K. Familial bladder cancer in the national Swedish family cancer database. J Urol. 2001;166:2129–33.CrossRefGoogle Scholar
  131. 131.
    Gabbani G, Hou SM, Nardini B, Marchioro M, Lambert B, Clonfero E. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis. 1996;17(8):1677–81.PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, et al. N-acetyltransferase 2 phenotype but not NAT1∗10 genotype affects aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomark Prev. 2000;9:619–23.Google Scholar
  133. 133.
    Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature. 1994;369:154–6.PubMedCrossRefPubMedCentralGoogle Scholar
  134. 134.
    Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso N, Autrup H, et al. N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene–environment interaction. Cancer Epidemiol Biomark Prev. 2000;9:461–7.Google Scholar
  135. 135.
    Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomark Prev. 2001;10(12):1249–52.Google Scholar
  136. 136.
    Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010;42(11):978–84.PubMedPubMedCentralCrossRefGoogle Scholar
  137. 137.
    Figueroa JD, Koutros S, Colt JS, Kogevinas M, Garcia-Closas M, Real FX, et al. Modification of occupational exposures on bladder cancer risk by common genetic polymorphisms. J Natl Cancer Inst. 2015;107(11):djv223.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.ISGlobal, Barcelona Institute for Global HealthBarcelonaSpain

Personalised recommendations